/SBRA

SBRA Stock - Sabra Health Care REIT, Inc.

Q: What is the analyst price target for SBRA?

Analyst price target information is not currently available for SBRA.

Q: What is SBRA's market cap?

Market capitalization information is not currently available for SBRA.

Real Estate|REIT - Healthcare Facilities|NASDAQ

$19.41-0.10%

$0.02 (-0.10%) • Jan 13

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+9.5%upside

Target: $21.25

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for SBRA

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.66

52W High$19.97

52W Low$15.60

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$703.24M	$647.51M	$624.81M	$569.54M	$598.57M
Gross Profit	$476.15M	$452.27M	$462.20M	$428.34M	$467.02M
Gross Margin	67.7%	69.8%	74.0%	75.2%	78.0%
Operating Income	$257.03M	$221.71M	$234.84M	$210.75M	N/A
Net Income	$126.71M	$13.76M	$-77,605,000	$-113,256,000	$138.42M
Net Margin	18.0%	2.1%	-12.4%	-19.9%	23.1%
EPS	$0.54	$0.06	$-0.34	$-0.52	$0.67

Company Overview

As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing - Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.

Visit Website

Earnings History & Surprises

SBRA

Beat Rate

56%

Last 18 quarters

Avg Surprise

+1.2%

EPS vs Estimate

Beats / Misses

10/2

6 met exactly

Latest EPS

$0.38

Q4 2025

EPS Surprise History

Q1 24

-2.9%

$0.33vs$0.34

Q2 24

+2.9%

$0.35vs$0.34

Q3 24

+2.9%

$0.36vs$0.35

Q4 24

+2.8%

$0.37vs$0.36

Q1 25

0.0%

$0.36vs$0.36

Q2 25

+2.8%

$0.37vs$0.36

Q3 25

+2.7%

$0.38vs$0.37

Q4 25

0.0%

$0.38vs$0.38

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 4, 2026	—	—	—	—
Q1 2026	Feb 18, 2026	$0.39	—	—	—
Q4 2025	Nov 5, 2025	$0.38	$0.38	0.0%	= MET
Q3 2025	Aug 4, 2025	$0.37	$0.38	+2.7%	✓ BEAT
Q2 2025	May 5, 2025	$0.36	$0.37	+2.8%	✓ BEAT
Q1 2025	Feb 19, 2025	$0.36	$0.36	0.0%	= MET
Q4 2024	Oct 31, 2024	$0.36	$0.37	+2.8%	✓ BEAT
Q3 2024	Aug 7, 2024	$0.35	$0.36	+2.9%	✓ BEAT
Q2 2024	May 8, 2024	$0.34	$0.35	+2.9%	✓ BEAT
Q1 2024	Feb 27, 2024	$0.34	$0.33	-2.9%	✗ MISS
Q4 2023	Nov 6, 2023	$0.34	$0.34	0.0%	= MET
Q3 2023	Aug 7, 2023	$0.34	$0.34	0.0%	= MET
Q2 2023	May 3, 2023	$0.34	$0.34	0.0%	= MET
Q1 2023	Feb 21, 2023	$0.36	$0.37	+2.8%	✓ BEAT
Q4 2022	Nov 7, 2022	$0.38	$0.36	-5.3%	✗ MISS
Q3 2022	Aug 3, 2022	$0.37	$0.39	+5.4%	✓ BEAT
Q2 2022	May 4, 2022	$0.38	$0.39	+2.6%	✓ BEAT
Q1 2022	Feb 22, 2022	$0.36	$0.37	+2.8%	✓ BEAT
Q4 2021	Nov 3, 2021	$0.38	$0.38	0.0%	= MET
Q3 2021	Aug 4, 2021	$0.38	$0.39	+2.6%	✓ BEAT

Frequently Asked Questions about SBRA

What is SBRA's current stock price?

Sabra Health Care REIT, Inc. (SBRA) is currently trading at $19.41 per share. The stock has moved -0.10% today.

What is the analyst price target for SBRA?

The average analyst price target for SBRA is $21.25, based on 1 analyst.

What sector is Sabra Health Care REIT, Inc. in?

Sabra Health Care REIT, Inc. operates in the Real Estate sector, specifically within the REIT - Healthcare Facilities industry. The company is traded on the NASDAQ exchange.

What is SBRA's market cap?

Sabra Health Care REIT, Inc. has a market capitalization of $4.62 billion, making it a mid-cap company.

Does SBRA pay dividends?

No, Sabra Health Care REIT, Inc. does not currently pay a dividend to shareholders.